Morning Market Gainers

shares jumped 28.90% to $17.16 after the company obtained rights to develop and commercialize a portfolio of preclinical compounds aimed at treating cancer from TransTech Pharma.

shares rose 18.31% to $1.68 on positive Phase 2 Tivozanib results. Aveo Oncology reported a Q4 loss of $0.27 per share.

shares jumped 15.66% to $6.50 after the company reported better-than-expected Q4 results.

shares jumped 14.44% to $16.09 on Q4 results.

rose 11.76% to $64.45 on buyout rumors.

shares gained 9.50% to $60.41 after the company reported upbeat Q4 earnings.

climbed 7.72% to $21.90. Finisar reported in-line earnings for the fiscal third quarter. However, the company issued a strong outlook for the current quarter.

shares climbed 7.62% to $5.65 after the company reported upbeat Q4 results and also announced the appointment of Rachel Glaser as CFO.

shares rose 4.44% to $59.56 after the company reported stronger-than-expected fiscal fourth-quarter results.